bpc-157 human clinical trials results 2025 2026 The “Wolverine” Drug – Ortho Rhode Island High-level overview of pathways modulated
Description
strongly elevated (NOS-2) and decreased (Cox2, VEGF-A, NOS-1, NOS-3, Nkap) gene expression
National Institute for Health and Care Excellence (NICE) Copyright NICE 2020
At the starting dose, it lasts only two weeks, which is less than ideal
If you are on a very low dose and want maximum precision, a 50-unit or 30-unit syringe provides finer graduations
